Mark Poznansky, MD, PhDMassachusetts General Hospital Antagonism of SDF-1 production by ovarian cancer and tumor immune control Immune cell migration into ovarian cancer is an important way in which the tumor is recognized as abnormal and killed by the immune system. Ovarian cancer tumors produce high amounts of a protein called SDF-1, thereby preventing immune […]
Read More
John Liao, M.D., Ph.D.University of Washington2018 James A. Harting Pilot Study Award Development of a vaccine to prevent serous tubal intraepithelial carcinoma High grade serous ovarian cancer does not originate in the ovary, as once thought, but on the fallopian tube. Precancerous fallopian tube cells (called serous tubal intraepithelial carcinoma or STIC) can go through […]
Read More